Accumulation of HIV-1 Drug Resistance Mutations After First-Line Immunological Failure to Evaluate the Options of Recycling NRTI Drugs in Second-Line Treatment: A Study from South India-Reference-Cited by-同舟云学术

Accumulation of HIV-1 Drug Resistance Mutations After First-Line Immunological Failure to Evaluate the Options of Recycling NRTI Drugs in Second-Line Treatment: A Study from South India

Published:2017-03 Issue:3 Volume:33 Page:271-274
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

Sivamalar Sathasivam¹,Dinesha Thongadi Ramesh¹,Gomathi Selvamurthi¹,Pradeep Ambrose¹,Boobalan Jayaseelan¹,Solomon Sunil S.¹²,Poongulali Selvamuthu¹,Solomon Suniti¹,Balakrishnan Pachamuthu¹,Saravanan Shanmugam¹

Affiliation:

1. Y.R. Gaitonde Center for AIDS Research and Education, Voluntary Health Services Hospital, Chennai, India.

2. Johns Hopkins University School of Medicine, Department of Medicine, Baltimore, Maryland.

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/aid.2016.0070

Reference15 articles.

1. The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings

2. The Emergence of Different Resistance Mechanisms toward Nucleoside Inhibitors Is Explained by the Properties of the Wild Type HIV-1 Reverse Transcriptase